First in Human Trial of TAS266 in Patients With Advanced Solid Tumors
Clinical trial NCT01529307 · TERMINATED
Trial details
- NCT number
- NCT01529307
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2012-09-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.